SEC Filing Update: #JUNS Jupiter Neurosciences, Inc. : $2.98

Sector: Healthcare | YTD: 🔽 -96.07% The SEC disclosed Today (22-SEP-2026) that PharmAla Biotech Holdings Inc. has Newly bought 132,867 #JUNS shares Ownership: 17.3% * Estimated Investment Value: $405.24K https://www.thinksabio.com/reports/isr/JUNS 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2102433218842481100 PharmAla Biotech Holdings Inc. acquired 132,867 shares of Junes Therapeutics Inc., bringing its ownership stake to 17.3% from a previous position of zero shares.